D. Scott LaMontagne

3.7k total citations · 1 hit paper
53 papers, 2.5k citations indexed

About

D. Scott LaMontagne is a scholar working on Epidemiology, Health and Microbiology. According to data from OpenAlex, D. Scott LaMontagne has authored 53 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Epidemiology, 38 papers in Health and 8 papers in Microbiology. Recurrent topics in D. Scott LaMontagne's work include Cervical Cancer and HPV Research (44 papers), Vaccine Coverage and Hesitancy (37 papers) and Hepatitis B Virus Studies (31 papers). D. Scott LaMontagne is often cited by papers focused on Cervical Cancer and HPV Research (44 papers), Vaccine Coverage and Hesitancy (37 papers) and Hepatitis B Virus Studies (31 papers). D. Scott LaMontagne collaborates with scholars based in United States, United Kingdom and India. D. Scott LaMontagne's co-authors include Katherine E. Gallagher, Deborah Watson‐Jones, Allison Bingham, Paul Bloem, María Brotons, Laia Bruni, Jennifer Kidwell Drake, Proma Paul, Mary E. Penny and Roberta Pastore and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Infectious Diseases.

In The Last Decade

D. Scott LaMontagne

52 papers receiving 2.5k citations

Hit Papers

HPV vaccination introduct... 2020 2026 2022 2024 2020 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010–2019
    2020 455 citations Laia Bruni, María Brotons et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Scott LaMontagne United States 27 2.0k 1.2k 412 317 306 53 2.5k
Christina Dorell United States 20 2.1k 1.0× 1.3k 1.1× 200 0.5× 281 0.9× 652 2.1× 23 2.9k
C. Robinette Curtis United States 14 2.5k 1.2× 1.3k 1.1× 244 0.6× 277 0.9× 807 2.6× 20 2.9k
Deborah Watson‐Jones United Kingdom 30 1.5k 0.7× 840 0.7× 307 0.7× 294 0.9× 336 1.1× 78 2.6k
Jenny Jeyarajah United States 16 2.1k 1.0× 1.1k 0.9× 199 0.5× 232 0.7× 649 2.1× 30 2.4k
Charnetta Williams United States 15 1.5k 0.8× 986 0.8× 189 0.5× 194 0.6× 345 1.1× 30 2.3k
Benjamin Fredua United States 12 1.6k 0.8× 1.0k 0.9× 169 0.4× 188 0.6× 381 1.2× 16 1.9k
Sara Boccalini Italy 24 1.3k 0.6× 849 0.7× 195 0.5× 185 0.6× 156 0.5× 145 2.0k
Rose M. Mays United States 16 1.1k 0.5× 756 0.6× 170 0.4× 259 0.8× 252 0.8× 29 1.5k
Markowitz Le United States 4 1.8k 0.9× 624 0.5× 121 0.3× 99 0.3× 562 1.8× 6 2.2k
Sarah Reagan-Steiner United States 11 1.0k 0.5× 514 0.4× 91 0.2× 125 0.4× 283 0.9× 23 1.6k

Countries citing papers authored by D. Scott LaMontagne

Since Specialization
Citations

This map shows the geographic impact of D. Scott LaMontagne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Scott LaMontagne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Scott LaMontagne more than expected).

Fields of papers citing papers by D. Scott LaMontagne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Scott LaMontagne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Scott LaMontagne. The network helps show where D. Scott LaMontagne may publish in the future.

Co-authorship network of co-authors of D. Scott LaMontagne

This figure shows the co-authorship network connecting the top 25 collaborators of D. Scott LaMontagne. A scholar is included among the top collaborators of D. Scott LaMontagne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Scott LaMontagne. D. Scott LaMontagne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Malvolti, Stefano, Paul Bloem, D. Scott LaMontagne, et al.. (2023). The Global Demand and Supply Balance of the Human Papillomavirus Vaccine: Implications for the Global Strategy for the Elimination of Cervical Cancer. Vaccines. 12(1). 4–4. 5 indexed citations
3.
Vodicka, Elisabeth, et al.. (2021). The projected cost-effectiveness and budget impact of HPV vaccine introduction in Ghana. Vaccine. 40. A85–A93. 16 indexed citations
4.
Plotnikoff, Kara M., Robine Donken, Laurie Smith, et al.. (2021). Priorities for sexually transmitted infection vaccine research and development: Results from a survey of global leaders and representatives. Vaccine X. 8. 100107–100107. 2 indexed citations
5.
Sanjosé, Sílvia de, María Brotons, D. Scott LaMontagne, & Laia Bruni. (2019). Human papillomavirus vaccine disease impact beyond expectations. Current Opinion in Virology. 39. 16–22. 39 indexed citations
6.
Anwari, Palwasha, Frédéric Debellut, Elisabeth Vodicka, et al.. (2019). Potential health impact and cost-effectiveness of bivalent human papillomavirus (HPV) vaccination in Afghanistan. Vaccine. 38(6). 1352–1362. 16 indexed citations
7.
Nguyen, Diep, Suzanne Hughes, Sam Egger, et al.. (2019). Risk of childhood mortality associated with death of a mother in low-and-middle-income countries: a systematic review and meta-analysis. BMC Public Health. 19(1). 1281–1281. 8 indexed citations
8.
Gallagher, Katherine E., D. Scott LaMontagne, & Deborah Watson‐Jones. (2018). Status of HPV vaccine introduction and barriers to country uptake. Vaccine. 36(32). 4761–4767. 174 indexed citations
9.
Tsu, Vivien, Tania Cernuschi, & D. Scott LaMontagne. (2014). Lessons Learned From HPV Vaccine Delivery in Low-Resource Settings and Opportunities for HIV Prevention, Treatment, and Care Among Adolescents. JAIDS Journal of Acquired Immune Deficiency Syndromes. 66(Supplement 2). S209–S216. 18 indexed citations
10.
11.
Katahoire, Anne, et al.. (2013). Acceptability of HPV Vaccine among Young Adolescent Girls in Uganda: Young People's Perspectives Count. 6(2). 211. 15 indexed citations
12.
Galagan, Sean R., et al.. (2013). Influences on parental acceptance of HPV vaccination in demonstration projects in Uganda and Vietnam. Vaccine. 31(30). 3072–3078. 33 indexed citations
13.
Bartolini, Rosario, Jennifer L. Winkler, Mary E. Penny, & D. Scott LaMontagne. (2012). Parental Acceptance of HPV Vaccine in Peru: A Decision Framework. 2 indexed citations
14.
Bartolini, Rosario, Jennifer L. Winkler, Mary E. Penny, & D. Scott LaMontagne. (2012). Parental Acceptance of HPV Vaccine in Peru: A Decision Framework. PLoS ONE. 7(10). e48017–e48017. 35 indexed citations
15.
16.
Bartolini, Rosario, Jennifer Kidwell Drake, Hilary Creed‐Kanashiro, et al.. (2010). Formative research to shape HPV vaccine introduction strategies in Peru Investigación formativa relacionada con el diseño de estrategias para introducir la vacuna contra el VPH en Perú. SHILAP Revista de lepidopterología. 1 indexed citations
17.
Bingham, Allison, Jennifer Kidwell Drake, & D. Scott LaMontagne. (2009). Sociocultural Issues in the Introduction of Human Papillomavirus Vaccine in Low-Resource Settings. Archives of Pediatrics and Adolescent Medicine. 163(5). 455–455. 108 indexed citations
18.
LaMontagne, D. Scott, KA Fenton, Jeanne M. Pimenta, et al.. (2005). Using chlamydia positivity to estimate prevalence: evidence from the Chlamydia Screening Pilot in England. International Journal of STD & AIDS. 16(4). 323–328. 11 indexed citations
19.
Randall, Sarah & D. Scott LaMontagne. (2005). Screening for chlamydia: seize the day. Journal of Family Planning and Reproductive Health Care. 31(2). 98–100. 2 indexed citations
20.
LaMontagne, D. Scott, David Fine, & Jeanne Marrazzo. (2003). Chlamydia trachomatis infection in asymptomatic men. American Journal of Preventive Medicine. 24(1). 36–42. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christina Dorell Breakdown of academic impact, for papers by C. Robinette Curtis Breakdown of academic impact, for papers by Deborah Watson‐Jones Breakdown of academic impact, for papers by Jenny Jeyarajah Breakdown of academic impact, for papers by Charnetta Williams Breakdown of academic impact, for papers by Benjamin Fredua Breakdown of academic impact, for papers by Sara Boccalini Breakdown of academic impact, for papers by Rose M. Mays Breakdown of academic impact, for papers by Markowitz Le Breakdown of academic impact, for papers by Sarah Reagan-Steiner
Rankless by CCL
2026